Literature DB >> 17016746

A marriage made in torsional space: using GALAHAD models to drive pharmacophore multiplet searches.

Jennifer K Shepphird1, Robert D Clark.   

Abstract

Pharmacophore multiplets are useful tools for 3D database searching, with the queries used ordinarily being derived from ensembles of random conformations of active ligands. It seems reasonable to expect that their usefulness can be augmented by instead using queries derived from single ligand conformations obtained from aligned ligands. Comparisons of pharmacophore multiplet searching using random conformations with multiplet searching using single conformations derived from GALAHAD (a genetic algorithm with linear assignment for hypermolecular alignment of datasets) models do indeed show that, while query hypotheses based on random conformations are quite effective, hypotheses based on aligned conformations do a better job of discriminating between active and inactive compounds. In particular, the hypothesis created from a neuraminidase inhibitor model was more similar to half of 18 known actives than all but 0.2% of the compounds in a structurally diverse subset of the World Drug Index. Similarly, a model developed from five angiotensin II antagonists yielded hypotheses that placed 65 known antagonists within the top 0.1-1% of decoy databases. The differences in discriminating power ranged from 2 to 20-fold, depending on the protein target and the type of pharmacophore multiplet used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016746     DOI: 10.1007/s10822-006-9070-2

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  8 in total

Review 1.  3-D pharmacophores in drug discovery.

Authors:  J S Mason; A C Good; E J Martin
Journal:  Curr Pharm Des       Date:  2001-05       Impact factor: 3.116

2.  Efficient generation, storage, and manipulation of fully flexible pharmacophore multiplets and their use in 3-D similarity searching.

Authors:  Edmond Abrahamian; Peter C Fox; Lars Naerum; Inge Thøger Christensen; Henning Thøgersen; Robert D Clark
Journal:  J Chem Inf Comput Sci       Date:  2003 Mar-Apr

3.  Generation of multiple pharmacophore hypotheses using multiobjective optimisation techniques.

Authors:  Simon J Cottrell; Valerie J Gillet; Robin Taylor; David J Wilton
Journal:  J Comput Aided Mol Des       Date:  2004-11       Impact factor: 3.686

4.  GALAHAD: 1. pharmacophore identification by hypermolecular alignment of ligands in 3D.

Authors:  Nicola J Richmond; Charlene A Abrams; Philippa R N Wolohan; Edmond Abrahamian; Peter Willett; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2006-10-19       Impact factor: 3.686

Review 5.  Computer design of bioactive compounds based on 3-D properties of ligands.

Authors:  Y C Martin
Journal:  NIDA Res Monogr       Date:  1993

6.  A genetic algorithm for flexible molecular overlay and pharmacophore elucidation.

Authors:  G Jones; P Willett; R C Glen
Journal:  J Comput Aided Mol Des       Date:  1995-12       Impact factor: 3.686

7.  Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.

Authors:  N R Taylor; A Cleasby; O Singh; T Skarzynski; A J Wonacott; P W Smith; S L Sollis; P D Howes; P C Cherry; R Bethell; P Colman; J Varghese
Journal:  J Med Chem       Date:  1998-03-12       Impact factor: 7.446

8.  Influenza virus neuraminidase inhibitors: generation and comparison of structure-based and common feature pharmacophore hypotheses and their application in virtual screening.

Authors:  Theodora Steindl; Thierry Langer
Journal:  J Chem Inf Comput Sci       Date:  2004 Sep-Oct
  8 in total
  14 in total

1.  GALAHAD: 1. pharmacophore identification by hypermolecular alignment of ligands in 3D.

Authors:  Nicola J Richmond; Charlene A Abrams; Philippa R N Wolohan; Edmond Abrahamian; Peter Willett; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2006-10-19       Impact factor: 3.686

2.  Managing bias in ROC curves.

Authors:  Robert D Clark; Daniel J Webster-Clark
Journal:  J Comput Aided Mol Des       Date:  2008-02-07       Impact factor: 3.686

3.  Using a staged multi-objective optimization approach to find selective pharmacophore models.

Authors:  Robert D Clark; Edmond Abrahamian
Journal:  J Comput Aided Mol Des       Date:  2008-07-29       Impact factor: 3.686

4.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  Therapeutic Targeting of Myc.

Authors:  Edward V Prochownik; Peter K Vogt
Journal:  Genes Cancer       Date:  2010-06

6.  Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors.

Authors:  Larissa de Mattos Oliveira; Janay Stefany Carneiro Araújo; David Bacelar Costa Junior; Isis Bugia Santana; Angelo Amâncio Duarte; Franco Henrique Andrade Leite; Raquel Guimarães Benevides; Manoelito Coelho Dos Santos Junior
Journal:  J Mol Model       Date:  2018-10-16       Impact factor: 1.810

7.  Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model.

Authors:  Gabriela Mustata; Ariele Viacava Follis; Dalia I Hammoudeh; Steven J Metallo; Huabo Wang; Edward V Prochownik; John S Lazo; Ivet Bahar
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

8.  Novel approach for efficient pharmacophore-based virtual screening: method and applications.

Authors:  Oranit Dror; Dina Schneidman-Duhovny; Yuval Inbar; Ruth Nussinov; Haim J Wolfson
Journal:  J Chem Inf Model       Date:  2009-10       Impact factor: 4.956

9.  PharmaGist: a webserver for ligand-based pharmacophore detection.

Authors:  Dina Schneidman-Duhovny; Oranit Dror; Yuval Inbar; Ruth Nussinov; Haim J Wolfson
Journal:  Nucleic Acids Res       Date:  2008-04-19       Impact factor: 16.971

10.  A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors.

Authors:  Huiding Xie; Lijun Chen; Jianqiang Zhang; Xiaoguang Xie; Kaixiong Qiu; Jijun Fu
Journal:  Int J Mol Sci       Date:  2015-05-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.